Servier, an independent international pharmaceutical company, and Poietis, a leader in the production of living bioprinted tissues, have announced a scientific partnership to use Poietis’s 4D bioprinting technology for the development and production of liver tissues.
19 septembre 2018
19 juin 2018
Poietis, a bioprinting leader, announces that it has closed a €5 million Series A financing round to accelerate technological developments that could lead to the first implantation of a bioprinted tissue into patients from 2021. This successful operation has been carried out through a new crowdfunding fundraising on WiSEED platform, the investment by the Nouvelle Aquitaine Coinvestment Fund as well as granting of non-dilutive funding obtained as part of the Worldwide Innovation Challenge.
27 mars 2018